XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 0.00 (-0.28%)
As of: Sep 30, 2026 · 10:23 AM EDT

XORTX Therapeutics (XRTX) Total Liabilities (2020 - 2026)

Updated

XORTX Therapeutics' Total Liabilities came in at $679,522 for the quarter ended Jun 30, 2026, down 4.5% from $711,455 a year earlier and down 21.1% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Total Liabilities (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics' Total Liabilities was $599,071, down 21.0% from the prior year.

  • Total Liabilities has declined in each of the last three years, with a five-year compound annual growth rate of -4.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Total Liabilities was $757,990 in the year ended Dec 31, 2024 (-8.2%), $825,938 in the year ended Dec 31, 2023 (-85.3%), $5.6 million in the year ended Dec 31, 2022 (+32.6%) and $4.23 million in the year ended Dec 31, 2021 (+447.6%).
  • The five-year range for quarterly Total Liabilities is -$4.15 million (the quarter ended Sep 30, 2021) to $5.37 million (the quarter ended Dec 31, 2022).
  • Year-over-year, Total Liabilities increased in two of the last eight quarters, with an average decline of 0.7%.
  • The fastest year-over-year change in Total Liabilities over five years came in the quarter ended Mar 31, 2024 (growth of 493.5%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 86.5%).
  • Business Quant data shows XRTX's Total Liabilities at $860,988 (quarter ended Mar 31, 2026), $599,071 (quarter ended Dec 31, 2025) and $837,408 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn - 679,522.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 679,522.00
Mar 31, 2026 860,988.00
Dec 31, 2025 599,071.00
Sep 30, 2025 837,408.00
Jun 30, 2025 711,455.00
Mar 31, 2025 757,350.00
Dec 31, 2024 757,990.00
Sep 30, 2024 1.72 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 3.56 Mn
Dec 31, 2023 825,938.00
Sep 30, 2023 553,757.00
Jun 30, 2023 403,262.00
Mar 31, 2023 599,788.00
Dec 31, 2022 5.37 Mn
Sep 30, 2022 3.26 Mn
Jun 30, 2022 2.98 Mn
Mar 31, 2022 3.98 Mn
Dec 31, 2021 4.20 Mn
Sep 30, 2021 -4.15 Mn
API Access

XORTX Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=XRTX&period=max&api_key=YOUR_API_KEY